Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Galapagos   /   Galapagos februari 2018

Aandeel Galapagos AEX:GLPG.NL, BE0003818359

Laatste koers (eur) Verschil Volume
22,740   -0,120   (-0,52%) Dagrange 22,620 - 22,860 63.316   Gem. (3M) 111,6K

Galapagos februari 2018

Volgen
4.984 Posts
Pagina: «« 1 ... 178 179 180 181 182 ... 250 »» | Laatste | Omlaag ↓
  7. Al Kipone 22 februari 2018 21:51
    Bank of Montreal Can increased its position in Galapagos NV (NASDAQ:GLPG) by 84.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,205 shares of the biotechnology company’s stock after buying an additional 2,377 shares during the period. Bank of Montreal Can’s holdings in Galapagos were worth $488,000 at the end of the most recent quarter.

    Several other large investors have also recently bought and sold shares of the stock. Orbimed Advisors LLC lifted its position in shares of Galapagos by 84.8% in the third quarter. Orbimed Advisors LLC now owns 523,790 shares of the biotechnology company’s stock worth $53,296,000 after buying an additional 240,290 shares in the last quarter. Alps Advisors Inc. increased its stake in Galapagos by 9.1% during the third quarter. Alps Advisors Inc. now owns 50,045 shares of the biotechnology company’s stock worth $5,092,000 after acquiring an additional 4,177 shares during the last quarter. Dorsey Wright & Associates increased its stake in Galapagos by 44.1% during the third quarter. Dorsey Wright & Associates now owns 48,357 shares of the biotechnology company’s stock worth $4,944,000 after acquiring an additional 14,788 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Galapagos by 7.1% during the third quarter. Bank of New York Mellon Corp now owns 40,813 shares of the biotechnology company’s stock worth $4,152,000 after acquiring an additional 2,720 shares during the last quarter. Finally, JPMorgan Chase & Co. bought a new stake in Galapagos during the third quarter worth approximately $3,072,000. Institutional investors own 19.49% of the company’s stock.
  18. Al Kipone 22 februari 2018 22:01
    Galapagos delivered in 2017
    22 February 2018 at 22:01 CET
    Key 2017 results:

    Expansion of filgotinib franchise:
    Start of 8 new disease area trials
    Opt-in to co-promote in Europe
    Second and third platform successes:
    Halt of disease progression in FLORA trial with GLPG1690 in IPF patients
    Promising results with MOR106 in atopic dermatitis patient trial
    ALBATROSS and FLAMINGO trials with GLPG2222 showed expected activity in cystic fibrosis patients
    Strong biomarker reduction and favorable tolerability with GLPG1972 in osteoarthritis patients
    Group revenues increased by €4.3 million to €155.9 million
    Operating loss increased by €78.3 million to €89.8 million
    Net loss of €115.7 million, compared to a net profit of €54.0 million in 2016
    Operational cash burn of €154.1 million
    Net proceeds from capital increase of €353.4 million
    Cash balance increased by €171.5 million to €1,152.4 million at year-end
4.984 Posts
Pagina: «« 1 ... 178 179 180 181 182 ... 250 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium

Er zitten de nodige haken en ogen aan opsplitsing van Galapagos

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Word Abonnee

Galapagos Nieuws

  1. IMCD uitblinker op goedgeluimd Damrak
  2. Van Lanschot: belangrijkste wending opsplitsing Galapagos is verandering Gilead-deal
  3. Mat begin beursdag vol nieuws van Galapagos, Samsung, Shell en Flow Traders
  4. Galapagos wil opsplitsen in twee beursnoteringen
  5. Galapagos: bemoedigende nieuwe resultaten met recidief/refractair non-Hodgkin lymfoom
  6. Kepler Cheuvreux zet Galapagos op verkooplijst
  7. Klinische resultaten Galapagos steunen celtherapie-hypothese
  8. Deutsche Bank verlaagt koersdoel Galapagos
  9. Financials en Shell doen goede zaken op terughoudend Damrak
  10. Galapagos herhaalt cash burn voor 2024